PT2515886T - Sistema terapêutico transdermal para a administração de rivastigmina ou de seus derivados - Google Patents
Sistema terapêutico transdermal para a administração de rivastigmina ou de seus derivadosInfo
- Publication number
- PT2515886T PT2515886T PT107905655T PT10790565T PT2515886T PT 2515886 T PT2515886 T PT 2515886T PT 107905655 T PT107905655 T PT 107905655T PT 10790565 T PT10790565 T PT 10790565T PT 2515886 T PT2515886 T PT 2515886T
- Authority
- PT
- Portugal
- Prior art keywords
- derivatives
- therapeutic system
- transdermal therapeutic
- administering rivastigmine
- rivastigmine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/00051—Accessories for dressings
- A61F13/00063—Accessories for dressings comprising medicaments or additives, e.g. odor control, PH control, debriding, antimicrobic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/00987—Apparatus or processes for manufacturing non-adhesive dressings or bandages
- A61F13/00991—Apparatus or processes for manufacturing non-adhesive dressings or bandages for treating webs, e.g. for moisturising, coating, impregnating or applying powder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T156/00—Adhesive bonding and miscellaneous chemical manufacture
- Y10T156/10—Methods of surface bonding and/or assembly therefor
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Emergency Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Manufacturing & Machinery (AREA)
- Psychology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Inorganic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Materials For Medical Uses (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP09180413 | 2009-12-22 | ||
EP10154648 | 2010-02-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
PT2515886T true PT2515886T (pt) | 2018-05-23 |
Family
ID=43383419
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT107905655T PT2515886T (pt) | 2009-12-22 | 2010-12-14 | Sistema terapêutico transdermal para a administração de rivastigmina ou de seus derivados |
Country Status (16)
Country | Link |
---|---|
US (1) | US8962014B2 (pt) |
EP (1) | EP2515886B1 (pt) |
JP (1) | JP6083734B2 (pt) |
KR (1) | KR101674240B1 (pt) |
CN (1) | CN102711744B (pt) |
AU (1) | AU2010335309B2 (pt) |
BR (1) | BR112012017168B1 (pt) |
CA (1) | CA2785117C (pt) |
CY (1) | CY1120283T1 (pt) |
DK (1) | DK2515886T3 (pt) |
ES (1) | ES2670227T3 (pt) |
MX (1) | MX350357B (pt) |
NO (1) | NO2515886T3 (pt) |
PL (1) | PL2515886T3 (pt) |
PT (1) | PT2515886T (pt) |
WO (1) | WO2011076621A2 (pt) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MY150626A (en) | 2009-10-30 | 2014-02-07 | Ix Biopharma Ltd | Fast dissolving solid dosage form |
DE102010026903A1 (de) | 2010-07-12 | 2012-01-12 | Amw Gmbh | Transdermales therapeutisches System mit Avocadoöl oder Palmöl als Hilfsstoff |
RS54173B1 (en) * | 2010-12-14 | 2015-12-31 | Acino Ag | TRANSDERMAL THERAPY SYSTEM FOR ACTIVE SUBSTANCE |
EP2711002A4 (en) * | 2011-05-20 | 2014-10-29 | Sk Chemicals Co Ltd | PLASTER WITH RIVASTIGMIN |
EP2729148A4 (en) | 2011-07-06 | 2015-04-22 | Parkinson S Inst | COMPOSITIONS AND METHODS FOR TREATING SYMPTOMS IN PATIENTS WITH PARKINSON'S DISEASE |
EP2752188B1 (en) | 2011-08-31 | 2020-05-06 | Toyo Ink Sc Holdings Co., Ltd. | Adhesive patch |
EP2594261A1 (en) | 2011-11-18 | 2013-05-22 | Labtec GmbH | Composition for transdermal administration of rivastigmine |
DE102012000369A1 (de) | 2012-01-11 | 2013-07-11 | Alfred E. Tiefenbacher (Gmbh & Co. Kg) | Transdermales therapeutisches System mit Cholinesterase-Hemmer |
JP5093545B1 (ja) * | 2012-02-28 | 2012-12-12 | ニチバン株式会社 | 貼付剤 |
US20140083878A1 (en) * | 2012-09-21 | 2014-03-27 | Mylan Inc. | Transdermal drug delivery device |
CN103933018A (zh) * | 2013-01-18 | 2014-07-23 | 江苏康倍得药业有限公司 | 一种透皮给药系统 |
US20180271800A1 (en) | 2017-03-24 | 2018-09-27 | E Ink California, Llc | Microcell systems for delivering active molecules |
JPWO2015174502A1 (ja) | 2014-05-15 | 2017-05-25 | ニチバン株式会社 | リバスチグミンを含有する貼付剤のための包装体 |
CA2962059C (en) | 2014-09-23 | 2020-03-24 | Equistar Chemicals, Lp | Polyolefin-based compositions, adhesives, and related multi-layered structures prepared therefrom |
CA2974324A1 (en) | 2015-01-28 | 2016-08-04 | Zita S. Netzel | Drug delivery methods and systems |
CA2977814A1 (en) | 2015-03-12 | 2016-09-15 | Chrono Therapeutics Inc. | Craving input and support system |
DE102015119789A1 (de) * | 2015-11-16 | 2017-05-18 | Denso-Holding Gmbh & Co. | Korrosionsschutzzusammensetzung umfassend Polyisobutylene |
CA3049529A1 (en) | 2017-01-06 | 2018-07-12 | Chrono Therapeutics Inc. | Transdermal drug delivery devices and methods |
US10646454B2 (en) | 2017-03-24 | 2020-05-12 | E Ink California, Llc | Microcell delivery systems including charged or magnetic particles for regulating rate of administration of actives |
JP6972334B2 (ja) | 2017-11-14 | 2021-11-24 | イー インク カリフォルニア, エルエルシー | 多孔性伝導電極層を含む電気泳動活性分子送達システム |
WO2019201755A1 (en) * | 2018-04-17 | 2019-10-24 | Lts Lohmann Therapie-Systeme Ag | Transdermal therapeutic system for the transdermal administration of solifenacin |
JP7420797B2 (ja) | 2018-05-29 | 2024-01-23 | モーニングサイド ベンチャー インベストメンツ リミテッド | 薬剤送達の方法及びシステム |
KR20220074962A (ko) | 2019-11-27 | 2022-06-03 | 이 잉크 캘리포니아 엘엘씨 | 전기 침식 밀봉층을 갖는 마이크로셀들을 포함하는 유익제 전달 시스템 |
WO2022093547A1 (en) | 2020-10-29 | 2022-05-05 | E Ink California, Llc | Microcell systems for delivering hydrophilic active molecules |
CN116322881A (zh) | 2020-10-29 | 2023-06-23 | 伊英克加利福尼亚有限责任公司 | 用于递送有益剂的微单元系统 |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU201906B (en) | 1987-03-04 | 1991-01-28 | Sandoz Ag | Process for producing phenyl-carbamate derivative and acid additional salts and pharmaceutical compositions containing them |
JPS63307818A (ja) | 1987-06-08 | 1988-12-15 | Sekisui Chem Co Ltd | 経皮吸収貼付剤 |
JPH07116025B2 (ja) | 1988-03-11 | 1995-12-13 | 積水化学工業株式会社 | 貼付剤 |
JP2693212B2 (ja) * | 1989-03-28 | 1997-12-24 | 日東電工株式会社 | 疾患治療用テープ製剤 |
JPH08193030A (ja) * | 1995-01-12 | 1996-07-30 | Nitto Denko Corp | エメダスチン貼付製剤 |
JPH10152434A (ja) | 1996-09-26 | 1998-06-09 | Nitto Denko Corp | 経皮吸収型製剤 |
GB9800526D0 (en) | 1998-01-12 | 1998-03-11 | Ciba Geigy Ag | Organic compounds |
DE19814087A1 (de) * | 1998-03-30 | 1999-10-14 | Lohmann Therapie Syst Lts | Feuchtigkeitsaktivierbares therapeutisches System |
DE19918106A1 (de) | 1999-04-22 | 2000-10-26 | Lohmann Therapie Syst Lts | Transdermales therapeutisches System mit neutralisierten Acrylathaftklebern |
DE10033853A1 (de) * | 2000-07-12 | 2002-01-31 | Hexal Ag | Transdermales therapeutisches System mit hochdispersem Siliziumdioxid |
DE10141652B4 (de) * | 2001-08-24 | 2011-04-07 | Lts Lohmann Therapie-Systeme Ag | Transdermales therapeutisches System auf der Basis von Polyacrylat-Haftklebern ohne funktionelle Gruppen und seine Verwendung |
JP4394443B2 (ja) * | 2001-10-17 | 2010-01-06 | 久光製薬株式会社 | 経皮吸収型製剤 |
JP4478757B2 (ja) | 2002-04-19 | 2010-06-09 | 日東電工株式会社 | ビソプロロール含有貼付剤 |
EP1830886B1 (en) * | 2004-12-27 | 2016-04-13 | Eisai R&D Management Co., Ltd. | Method for stabilizing anti-dementia drug |
TWI389709B (zh) * | 2005-12-01 | 2013-03-21 | Novartis Ag | 經皮治療系統 |
CN1994290B (zh) * | 2006-01-04 | 2011-03-16 | 上海医药工业研究院 | 卡巴拉汀透皮贴剂及其制备方法 |
CA2651596C (en) * | 2006-05-08 | 2014-03-25 | Teikoku Seiyaku Co., Ltd. | Percutaneous absorption preparations of antidementia drugs |
US9248104B2 (en) * | 2006-08-17 | 2016-02-02 | Core Tech Solutions, Inc. | Transdermal methods and systems for treating Alzheimer's disease |
JP2009022730A (ja) * | 2007-06-18 | 2009-02-05 | Kyoritsu Yakuhin Kogyo Kk | 貼付剤 |
-
2010
- 2010-12-14 WO PCT/EP2010/069654 patent/WO2011076621A2/de active Application Filing
- 2010-12-14 KR KR1020127017374A patent/KR101674240B1/ko active IP Right Grant
- 2010-12-14 BR BR112012017168-2A patent/BR112012017168B1/pt active IP Right Grant
- 2010-12-14 EP EP10790565.5A patent/EP2515886B1/de active Active
- 2010-12-14 DK DK10790565.5T patent/DK2515886T3/en active
- 2010-12-14 JP JP2012545226A patent/JP6083734B2/ja active Active
- 2010-12-14 NO NO10790565A patent/NO2515886T3/no unknown
- 2010-12-14 ES ES10790565.5T patent/ES2670227T3/es active Active
- 2010-12-14 CN CN201080059296.4A patent/CN102711744B/zh active Active
- 2010-12-14 US US13/518,006 patent/US8962014B2/en active Active
- 2010-12-14 PL PL10790565T patent/PL2515886T3/pl unknown
- 2010-12-14 CA CA2785117A patent/CA2785117C/en active Active
- 2010-12-14 PT PT107905655T patent/PT2515886T/pt unknown
- 2010-12-14 MX MX2012007214A patent/MX350357B/es active IP Right Grant
- 2010-12-14 AU AU2010335309A patent/AU2010335309B2/en active Active
-
2018
- 2018-05-25 CY CY20181100570T patent/CY1120283T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
EP2515886A2 (de) | 2012-10-31 |
JP2013515025A (ja) | 2013-05-02 |
CY1120283T1 (el) | 2019-07-10 |
NO2515886T3 (pt) | 2018-09-08 |
KR20120128606A (ko) | 2012-11-27 |
MX350357B (es) | 2017-09-05 |
KR101674240B1 (ko) | 2016-11-08 |
PL2515886T3 (pl) | 2018-08-31 |
WO2011076621A3 (de) | 2012-02-09 |
ES2670227T3 (es) | 2018-05-29 |
CA2785117A1 (en) | 2011-06-30 |
DK2515886T3 (en) | 2018-06-14 |
CN102711744B (zh) | 2014-06-25 |
BR112012017168A2 (pt) | 2018-05-02 |
BR112012017168B1 (pt) | 2022-03-15 |
EP2515886B1 (de) | 2018-04-11 |
CA2785117C (en) | 2016-12-06 |
CN102711744A (zh) | 2012-10-03 |
JP6083734B2 (ja) | 2017-02-22 |
AU2010335309A1 (en) | 2012-07-19 |
US20130261571A1 (en) | 2013-10-03 |
WO2011076621A2 (de) | 2011-06-30 |
US8962014B2 (en) | 2015-02-24 |
AU2010335309B2 (en) | 2015-08-20 |
MX2012007214A (es) | 2012-09-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT2515886T (pt) | Sistema terapêutico transdermal para a administração de rivastigmina ou de seus derivados | |
EP2560624A4 (en) | THERAPEUTIC FORMULATION TO REDUCE THE SIDE EFFECTS OF MEDICATION | |
EP2299989A4 (en) | STABILIZED TRANSDERMAL DRUG DISPENSING SYSTEM | |
EP2240236A4 (en) | SKIN THERAPY SYSTEM | |
IL221007A (en) | Pharmaceutical combinations for antiviral therapy | |
IL214402A0 (en) | Transdermal pharmaceutical preparations | |
EP2392307A4 (en) | DEVICE FOR CONTROLLING DOSAGE OF DRUG SOLUTION | |
ZA201303965B (en) | Transdermal therapeutic system for administering an active substance | |
EP2424611A4 (en) | DEVICE FOR TRANSDERMAL ADMINISTRATIONS | |
PT2464342E (pt) | Novas formulações farmacêuticas para prevenir a utilização indevida de medicamentos | |
HK1184370A1 (zh) | 用於治療疼痛的藥物組合 | |
AP3250A (en) | Tablets for combination therapy | |
ZA201005663B (en) | Transdermal therapeutic system having stabilized membrane | |
ZA201403497B (en) | Transdermal therapeutic system for administering fentanyl or analogue thereof | |
GB0906159D0 (en) | Drug combination for the treatment of proteostatic diseases | |
ZA200809004B (en) | Autodestructive transdermal therapeutic system | |
ZA201301458B (en) | Therapeutic agent for pain | |
PL385972A1 (pl) | Kompozycja farmaceutyczna do leczenia chorób przyzębia | |
EP2486929A4 (en) | ANTI-TUMOR THERAPEUTIC AGENT | |
ZA201201894B (en) | Pharmaceutical combination for treating tumor | |
EP2460524A4 (en) | MEDICAL COMPOSITION FOR IDE IONTOPHORESIS | |
EP2485719A4 (en) | TRANSDERMAL THERAPEUTIC SYSTEM | |
EP2548580A4 (en) | PHARMACEUTICAL FOR PSEUDOTRAINING THERAPY | |
EP2474325A4 (en) | DRUG COMPOSITION FOR TREATMENT OF ANGIOGENESIS | |
IL200682A (en) | A device for introducing drugs |